FHB
ALXN

First Hawaiian Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

First Hawaiian Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,908
Closed -$351K – 892
2021
Q2 		$351K Sell
1,908
-688
-27% -$118K 0.01% 655
2021
Q1 		$397K Hold
2,596
– – 0.02% 621
2020
Q4 		$406K Sell
2,596
-770
-23% -$98.9K 0.02% 556
2020
Q3 		$385K Sell
3,366
-701
-17% -$75.6K 0.02% 513
2020
Q2 		$456K Buy
4,067
+661
+19% +$70.2K 0.02% 451
2020
Q1 		$305K Sell
3,406
-440
-11% -$43.2K 0.02% 533
2019
Q4 		$416K Buy
3,846
+435
+13% +$46.5K 0.02% 550
2019
Q3 		$334K Buy
3,411
+670
+24% +$75.5K 0.02% 613
2019
Q2 		$359K Sell
2,741
-1,059
-28% -$136K 0.02% 580
2019
Q1 		$514K Buy
3,800
+1,105
+41% +$137K 0.03% 432
2018
Q4 		$262K Buy
2,695
+1,963
+268% +$232K 0.02% 628
2018
Q3 		$102K Buy
+732
New +$91.8K 0.01% 938

Other funds holding ALXN

Brinker Capital Investments
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TD Ameritrade Investment Management
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

First Hawaiian Bank's ALXN Position: Q3 2021 in Review

First Hawaiian Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,908 shares — an estimated $351K sold.

First Hawaiian Bank first reported a position in ALXN in Q3 2018 and held it in 12 quarters. The position peaked at $514K in Q1 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • First Hawaiian Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • First Hawaiian Bank sold 1,908 Alexion Pharmaceuticals shares in Q3 2021, an estimated $351K.
  • First Hawaiian Bank first reported a position in Alexion Pharmaceuticals in Q3 2018 and held it in 12 quarters.
  • First Hawaiian Bank's Alexion Pharmaceuticals position peaked at $514K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on First Hawaiian Bank's 13F filing for Q3 2021, filed 12 Oct 2021.